STANFORD UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-11-11

Employees: 10K

Market Cap: -

Website: http://www.stanford.edu

Clinical Trials

Documentary to Encourage Plant-based Eating

Not Applicable

Completed

Conditions: Eating Behavior

Interventions: Behavioral: Documentary
Behavioral: Control

First Posted Date: 2020-08-11

Last Posted Date: 2021-03-17

Lead Sponsor: Stanford University

Target Recruit Count: 650

Registration Number: NCT04507087

Locations: 🇺🇸
Maya Mathur, Palo Alto, California, United States

Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCT

Phase 1

Completed

Conditions: Venous Thromboembolism

Interventions: Drug: Enoxaparin 40Mg/0.4mL Prefilled Syringe
Drug: Apixaban 2.5 MG Oral Tablet

First Posted Date: 2020-08-07

Last Posted Date: 2024-07-25

Lead Sponsor: Stanford University

Target Recruit Count: 82

Registration Number: NCT04504318

Locations: 🇺🇸
Stanford University Medical Center, Stanford, California, United States

Perioperative Optimization With Enhanced Recovery

Not Applicable

Active, not recruiting

Conditions: Complication of Surgical Procedure

Interventions: Behavioral: POWER

First Posted Date: 2020-08-07

Last Posted Date: 2024-03-15

Lead Sponsor: Stanford University

Target Recruit Count: 368

Registration Number: NCT04504266

Locations: 🇺🇸
Stanford Health Care, Stanford, California, United States

The Effect of an ASC-seeded Collagen Hydrogel on Cerebrospinal Fluid Leak Rates Following Skull Base Surgery

Not Applicable

Withdrawn

Conditions: CSF Leak

Interventions: Device: Duragen with Collagen Hydrodel and ASCs

First Posted Date: 2020-08-07

Last Posted Date: 2022-08-29

Lead Sponsor: Stanford University

Registration Number: NCT04503161

Limiting AAA With Metformin (LIMIT) Trial

Phase 2

Recruiting

Conditions: Abdominal Aortic Aneurysm

Interventions: Other: Placebo
Drug: Metformin

First Posted Date: 2020-08-05

Last Posted Date: 2024-01-10

Lead Sponsor: Stanford University

Target Recruit Count: 480

Registration Number: NCT04500756

Locations: 🇺🇸
Stanford Hospital and Clinics, Stanford, California, United States

Immune Modulation by Enhanced vs Standard Prehabilitation Program Before Major Surgery

Not Applicable

Completed

Conditions: Gastrointestinal Disease
Preoperative Care
Urological Disease
Surgery
Immune System and Related Disorders
Gynecologic Disease
Thoracic Diseases

Interventions: Behavioral: Physical Prehabilitation
Behavioral: Stress Reduction Prehabilitation
Behavioral: Cognitive Prehabilitation
Behavioral: Nutrition Prehabilitation

First Posted Date: 2020-08-04

Last Posted Date: 2024-04-23

Lead Sponsor: Stanford University

Target Recruit Count: 55

Registration Number: NCT04498208

Locations: 🇺🇸
Stanford University, Stanford, California, United States

Comparison of Concussion Education Programs

Not Applicable

Completed

Conditions: Concussion, Brain

Interventions: Other: Education

First Posted Date: 2020-07-30

Last Posted Date: 2020-07-30

Lead Sponsor: Stanford University

Target Recruit Count: 118

Registration Number: NCT04492696

Locations: 🇺🇸
Stanford University, Stanford, California, United States

Early Percutaneous Cryoablation for Pain Control After Rib Fractures Among Elderly Patients

Not Applicable

Active, not recruiting

Conditions: Rib Fractures

Interventions: Radiation: Cryoneurolysis
Other: Standard of Care

First Posted Date: 2020-07-22

Last Posted Date: 2024-05-16

Lead Sponsor: Stanford University

Target Recruit Count: 110

Registration Number: NCT04482582

Locations: 🇺🇸
Stanford Hospital and Clinics, Palo Alto, California, United States

Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 Patients

Not Applicable

Withdrawn

Conditions: Diagnoses Disease
Covid19

Interventions: Behavioral: Doctorgram Patient Kit

First Posted Date: 2020-07-21

Last Posted Date: 2022-01-31

Lead Sponsor: Stanford University

Registration Number: NCT04480411

Locations: 🇺🇸
Stanford University, Stanford, California, United States

Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma

Phase 1

Active, not recruiting

Conditions: Glioblastoma
Newly Diagnosed Glioblastoma

Interventions: Device: Optune
Drug: Gadolinium
Drug: Temozolomide
Radiation: Stereotactic radiosurgery (SRS)

First Posted Date: 2020-07-16

Last Posted Date: 2024-12-27

Lead Sponsor: Stanford University

Target Recruit Count: 12

Registration Number: NCT04474353

Locations: 🇺🇸
Stanford University, Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy